These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3301644)

  • 1. Clinical trial of a sustained release theophylline tablet in adult asthmatics.
    Dhand R; Malik SK; Garg SK; Bhutani JK; Swaminathan S
    Indian J Chest Dis Allied Sci; 1986; 28(4):212-21. PubMed ID: 3301644
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of sustained release theophylline (Pro-Vent), in asthma.
    Wallis PJ; Joy M; Hughes DT; Empey DW
    Br J Clin Pract; 1985 Sep; 39(9):341-5. PubMed ID: 3904796
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study comparing Pro-Vent and phyllocontin in stable asthmatics.
    Sivananthan N; Kana D; Winson MD; Roberts KN
    Br J Clin Pract; 1988 Dec; 42(12):498-500. PubMed ID: 3076785
    [No Abstract]   [Full Text] [Related]  

  • 6. A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels.
    Rachelefsky GS; Katz RM; Siegel SC
    Ann Allergy; 1978 Apr; 40(4):252-7. PubMed ID: 345889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of two theophylline derivatives in asthmatic patients.
    Jones RW
    J Int Med Res; 1979; 7 Suppl 1():16-21. PubMed ID: 374160
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-functional study of the activity of a new xanthine derivative: bamifylline].
    Finiguerra M; Morandini GC
    Clin Ter; 1986 Jul; 118(2):125-35. PubMed ID: 3527540
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison between effects of aminophylline, proxyphylline and terbutaline in asthmatics.
    Svedmyr K; Mellstrand T; Svedmyr N
    Scand J Respir Dis Suppl; 1977; 101():139-46. PubMed ID: 343235
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y
    Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.
    Saccar CL; Green LD; Helsel CL; Niehls ME; Diconcetto JA; Mansmann HC; McGeady SJ
    Ann Allergy; 1983 Apr; 50(4):245-8. PubMed ID: 6340563
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polysomnographic measurements in early and late administration (18.00 vs. 22.00 hours) of retarded theophylline in bronchial asthma].
    Rühle KH; Horn H; Hagenmeier A; Würtemberger G; Schmitz-Schumann M; Matthys H
    Prax Klin Pneumol; 1987 May; 41(5):180-6. PubMed ID: 3299354
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the pharmacokinetics of theophylline and its effect on respiratory impedance in asthmatic patients after multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Nosaka H; Satake T; Hasegawa T; Ogura Y; Mizukami Y
    Arerugi; 1986 May; 35(5):320-8. PubMed ID: 3753206
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of nocturnal bronchial asthma: comparison of various doses of retard theophylline].
    Dorow P; Steinijans VW
    Prax Klin Pneumol; 1987 Oct; 41(10):442-4. PubMed ID: 3325964
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained-release theophylline preparations.
    Drug Ther Bull; 1985 May; 23(9):33-6. PubMed ID: 3888583
    [No Abstract]   [Full Text] [Related]  

  • 20. [A comparative study of Unixan administered once daily and Theo-Dur administered twice daily].
    Dahl R; Pedersen B
    Ugeskr Laeger; 1986 Sep; 148(40):2548-51. PubMed ID: 3535197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.